Evidence map›Paper›PMID 31103381›Full record

ArticleImmunity2019

Cytomegalovirus Infection Drives Avidity Selection of Natural Killer Cells.

Nicholas M Adams, Clair D Geary, Endi K Santosa, Dianne Lumaquin, Jean-Benoît Le Luduec, Rosa Sottile, Kattria van der Ploeg, Joy Hsu, Benjamin M Whitlock, Benjamin T Jackson and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 57 citations in OpenAlex.

  1. Clonal selection of somatic mutations shapes NK cell memory.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. CD94The European respiratory journal · 2024
    Article
  7. Article
  8. Loss of circulating CD8αbioRxiv : the preprint server for biology · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Nicholas M AdamsImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Clair D GearyImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Endi K SantosaImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Dianne LumaquinImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Jean-Benoît Le LuduecImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Rosa SottileImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Kattria van der PloegImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Joy HsuImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Benjamin M WhitlockImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Benjamin T JacksonImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Orr-El WeizmanImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Morgan HuseImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Katharine C HsuImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Joseph C SunImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: sunj@mskcc.org.
Memorial Sloan Kettering Cancer Center · USCornell University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
T LYMPHOCYTE SUBSET FUNCTION POST-TRANSPLANTATIONP01CA023766 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SCHEINBERG, DAVID A · 1985 to 2023
$59.0M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
The natural killer cell response against mouse cytomegalovirus infectionR01AI100874 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Joseph Chai-Yuen Sun · 2012 to 2026
$7.4M
Synaptic Control of Cytotoxic T cell FunctionR01AI087644 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI HUSE, MORGAN A · 2010 to 2025
$7.3M
Regulation of Nfil3 in innate lymphocyte-mediated host immunityR01AI130043 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI SUN, JOSEPH CHAI-YUEN · 2017 to 2021
$2.8M
Natural killer cell and T-cell crosstalk in CMV infectionR56AI123658 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI HSU, KATHARINE C · 2017 to 2017
$306k
Elucidating the function of IRF8 during antiviral natural killer cell responsesF30AI136239 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ADAMS, NICHOLAS M · 2018 to 2019
$84k
NCI NIH HHS P01 CA023766NCI NIH HHS P30 CA008748NIAID NIH HHS F30 AI136239NIAID NIH HHS R01 AI087644NIAID NIH HHS R01 AI100874NIAID NIH HHS R01 AI130043NIAID NIH HHS R56 AI123658NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

The process of affinity maturation, whereby T and B cells bearing antigen receptors with optimal affinity to the relevant antigen undergo preferential expansion, is a key feature of adaptive immunity. Natural killer (NK) cells are innate lymphocytes capable of "adaptive" responses after cytomegalovirus (CMV) infection. However, whether NK cells are similarly selected on the basis of their avidity for cognate ligand is unknown. Here, we showed that NK cells with the highest avidity for the mouse CMV glycoprotein m157 were preferentially selected to expand and comprise the memory NK cell pool, whereas low-avidity NK cells possessed greater capacity for interferon-γ (IFN-γ) production. Moreover, we provide evidence for avidity selection occurring in human NK cells during human CMV infection. These results delineate how heterogeneity in NK cell avidity diversifies NK cell effector function during antiviral immunity, and how avidity selection might serve to produce the most potent memory NK cells.

Indexed as

AnimalsCytomegalovirusCytomegalovirus InfectionsCytotoxicity, ImmunologicGene Expression RegulationHerpesviridae InfectionsHost-Pathogen InteractionsHumansImmunologic MemoryKiller Cells, NaturalLymphocyte ActivationMiceMice, KnockoutMuromegalovirusNK Cell Lectin-Like Receptor Subfamily AT-Cell Antigen Receptor SpecificityNK Cell Lectin-Like Receptor Subfamily AcytomegalovirusheterogeneityNK cellsselectionviral infection

Identifiers

PMID31103381
PMCPMC6614060
OpenAlexW2945239922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.